Alcoholic Hepatitis: Pathogenesis and Approaches to Treatment

References

• Maddrey WC. Alcoholic hepatitis: clinicopa-thologic features and therapy. Sem Liv Dis 1988; 8: 91–102
   PubMed Web of Science ®Google Scholar
• Lieber CS. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N Engl J Med 1988; 319: 1639–1650
   PubMed Web of Science ®Google Scholar
• Galambos JT. Alcoholic hepatitis: its therapy and prognosis. Prog Liv Dis 1973; 4: 567–588
   Google Scholar
• Peters TJ, Ward RJ. Role of acetaldehyde in the pathogenesis of alcoholic liver disease. Molec Aspects Med 1988; 10: 179–190
   PubMedGoogle Scholar
• Lauterburg B H, Bilzer M. Mechanisms of acetaldehyde hepatotoxicity. J Hepatol 1988; 7: 384–390
   PubMed Web of Science ®Google Scholar
• Patek AJ, Jr, Toth I G, Saunders M G, Castro G AM, Engel JJ. Alcohol and dietary factors in cirrhosis. An epidemiological study of 304 alcoholic patients. Arch Intern Med 1975; 1345: 1053–1057
   Google Scholar
• Mendenhall C L, Anderson S, Weesner R E, et al. Protein-calorie malnutrition associated with alcoholic hepatitis. Am J Med 1984; 76: 211–222
   PubMed Web of Science ®Google Scholar
• Lieber C S, Leo MA. Interaction of alcohol and nutritional factors with hepatic fibrosis. Prog Liv Dis 1986; 8: 253–272
   PubMedGoogle Scholar
• Lelbach WK. Quantitative aspects of drinking in alcoholic liver cirrhosis. Alcoholic liver pathology. Addiction Research Foundation of Ontario, JM Khanna, Y Israel, H Kalant, Toronto 1975; 1–18
   Google Scholar
• Pequingnot G, Chabert C, Eydoux H, et al. Increased risk of liver cirrhosis with intake of alcohol. Rev. Alcohol 1974; 20: 191–202
   Google Scholar
• Grant B F, Dufour M C, Harford TC. Epidemiology of alcoholic liver disease. Sem Liv Dis 1988; 8: 12–25
   PubMed Web of Science ®Google Scholar
• Sorensen T IA. Alcohol and liver injury: dose-related or permissive effect?. Liver 1989; 9: 189–197
   PubMedGoogle Scholar
• Orrego H, Blendis L M, Blake J E, Kapur B M, Israel Y. Reliability of assessment of alcohol intake based on personal interviews in a liver clinic. Lancet 1979; 2: 1354–1356
   PubMedGoogle Scholar
• Morgan M Y, Sherlock S. Sex-related differences among 100 patients with alcoholic liver disease. Br Med J 1977; 1: 939–941
   PubMed Web of Science ®Google Scholar
• Milman N, Gradual N, Strom P, Franzmann M-B. Alcoholic hepatitis in females. Acta Med Scand 1988; 223: 119–124
   PubMedGoogle Scholar
• Johnson R D, Williams R. Genetic and environmental factors in the individual susceptibility to the development of alcoholic liver disease. Gastroenterology 1981; 81: 616–624
   PubMedGoogle Scholar
• Bird G LA, Williams R. Factors determining cirrhosis in alcoholic liver disease. Molec Aspects Med 1988; 10: 97–105
   PubMedGoogle Scholar
• Bosron W F, Lumeng L, Li T-K. Genetic polymorphism of enzymes of alcohol metabolism and susceptibility to alcoholic liver disease. Molec Aspects Med 1988; 10: 147–158
   PubMedGoogle Scholar
• Iturriaga H, Bunout D, Hirsch S, Ugarte G. Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics. Am J Clin Nutr 1988; 47: 235–238
   PubMed Web of Science ®Google Scholar
• Zetterman R K, Sorrell MF. Immunologic aspects of alcoholic liver disease. Gastroenterology 1981; 81: 616–624
   PubMed Web of Science ®Google Scholar
• Eddleston A WLF, Vento S. Relevance of immune mediated mechanisms in progressive alcoholic liver injury. Molec Aspects Med 1988; 10: 169–177
   PubMedGoogle Scholar
• Israel Y, Orrego H, Niemela O. Immune responses to alcohol metabolites: pathogenic and diagnostic implications. Sem Liv Dis 1988; 8: 81–90
   PubMedGoogle Scholar
• Williams A JK, Barry RE. Free radical generation by neutrophils: a potential mechanism of cellular injury in acute alcoholic hepatitis. Gut 1987; 28: 1157–1161
   PubMed Web of Science ®Google Scholar
• Zetterman R K, Luisada-Opper A, Leevy CM. Alcoholic hepatitis. Cell-mediated immunological response to alcoholic hyaline. Gastroenterology 1976; 70: 382–384
   PubMed Web of Science ®Google Scholar
• Diehl A M, Chacon M, Wagner P. The effect of chronic ethanol feeding on ornithine decarboxylase activity and liver regeneration. Hepatology 1988; 8: 237–242
   PubMedGoogle Scholar
• Baskin G, Henderson G I, Schenker S. Ethanol and hepatic regeneration. Hepatology 1988; 8: 408–411
   PubMedGoogle Scholar
• Mills P R, Pennington T H, Kay R, et al. Hepatitis B Antibody in alcoholic cirrhosis. J Clin Pathol 1979; 32: 778–782
   PubMed Web of Science ®Google Scholar
• Inoue K, Kojima T, Koyata H, et al. Hepatitis B virus antigen and antibodies in alcoholics. Liver 1985; 5: 247–252
   PubMedGoogle Scholar
• Hislop W S, Follett E AC, Bouchier I AD, et al. Serological markers of hepatitis B in patients with alcoholic liver disease: a multi-centre survey. J Clin Pathol 1981; 34: 1017–1019
   PubMed Web of Science ®Google Scholar
• Fong T-L, Govindarajan S, Valinluck B, Redeker AG. Status of hepatitis B virus DNA in alcoholic liver disease: a study of a large urban population in the United States. Hepatology 1988; 8: 1602–1604
   PubMedGoogle Scholar
• Nolan JP. Intestinal endotoxins as mediators of hepatic injury–an idea whose time has come again. Hepatology 1989; 10: 887–891
   PubMed Web of Science ®Google Scholar
• Fox E S, Thomas P, Broitman SA. Comparative studies of endotoxin uptake by isolated rat Kupffer and peritoneal cells. Infect Immun 1987; 55: 2962–2966
   PubMedGoogle Scholar
• Arthur M JP, Kowalski-Saunders P, Wright R. Corynebacterium parpum-elicited hepatic macrophages demonstrate enhanced respiratory burst activity compared with resident Kupffer cells in the rat. Gastroenterology 1986; 91: 174–181
   PubMed Web of Science ®Google Scholar
• Arai M, Nakano S, Okuno F, et al. Endotoxin-induced hypercoagulability: a possible aggravating factor of alcoholic liver disease. Hepatology 1989; 9: 846–851
   PubMed Web of Science ®Google Scholar
• McClain C J, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989; 9: 349–351
   PubMed Web of Science ®Google Scholar
• Thiele DL. Tumor necrosis factor, the acute phase response and the pathogenesis of alcoholic liver disease. Hepatology 1989; 9: 497–499
   PubMedGoogle Scholar
• West M A, Billiar T R, Curran R D, Hyland B J, Simmons RL. Evidence that rat Kupffer cells stimulate and inhibit hepatocyte protein synthesis in vitro by different mechanisms. Gastroenterology 1989; 96: 1572–1582
   PubMedGoogle Scholar
• Maddrey WC. Hepatic effects of acetaminophen: enhanced toxicity in alcoholics. J Clin Gastroenterol 1987; 9: 180–185
   PubMed Web of Science ®Google Scholar
• Jewell S A, DiMonte D, Gentile A, Guglielmi A, Altomare E, Albano O. Decreased hepatic glutathione in chronic alcoholic patients. J Hepatol 1986; 3: 1–6
   PubMedGoogle Scholar
• Lauterburg B H, Velez ME. Glutathione deficiency in alcoholics: risk factor for paracetamol hepato-toxicity. Gut 1988; 29: 1153–1157
   PubMed Web of Science ®Google Scholar
• Desmet VJ. Alcoholic liver disease. Histologic features and evolution. Acta Med Scand 1986; 703: 111–126
   Google Scholar
• MacSween R NM, Burt AD. Histologic spectrum of alcoholic liver disease. Sem Liv Dis 1986; 6: 221–229
   PubMedGoogle Scholar
• Uchida T, Shikata T, Govindarajan S, Kronborg I. The characteristics of alcoholic liver disease in Japan. Clinicopathologic comparison with alcoholic liver disease in the United States. Liver 1987; 7: 290–297
   PubMedGoogle Scholar
• Orrego H, Israel Y, Blendis LM. Alcoholic liver disease: information in search of knowledge?. Hepatology 1981; 1: 267–283
   PubMed Web of Science ®Google Scholar
• Sorensen T IA, Orholm M, Bentsen K, Hoybye G, Ughoje K, Christoffersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984; 2: 241–244
   PubMed Web of Science ®Google Scholar
• Marbet U A, Bianchi L, Meury U, Stalder GA. Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease. J Hepatol 1987; 4: 364–372
   PubMed Web of Science ®Google Scholar
• Gluud C, Henriksen J H, Nielsen G. The Copenhagen Study Group for Liver Diseases. Prognostic indicators in alcoholic cirrhotic men. Hepatology 1988; 8: 222–227
   PubMed Web of Science ®Google Scholar
• Perrillo R P, Griffin R, DeSchryver-Kecshemeti K, et al. Alcoholic liver disease presenting with marked elevation of serum alkaline phosphatase: a combined clinical and pathological study. Am J Dig Dis 1978; 23: 1061–1066
   PubMedGoogle Scholar
• Glover S C, McPhie J L, Brunt PW. Cholestasis in acute alcoholic liver disease. Lancet 1977; 2: 1305–1307
   PubMedGoogle Scholar
• Atterbury CE. Should we routinely perform liver biopsy in suspected alcoholic liver disease?. J Clin Gastroenterol 1988; 10: 605–607
   PubMedGoogle Scholar
• Cohen JA, Kaplan MM. The SGOT/SGPT ratio– an indicator of alcoholic liver disease. Dig Dis Sci 1979; 24: 835–838
   PubMed Web of Science ®Google Scholar
• Annoni G, Colombo M, Christina M, et al. Serum type III procollagen peptide and laminin (Lam-PI) detect alcoholic hepatitis in chronic alcohol abusers. Hepatology 1989; 9: 693–697
   PubMedGoogle Scholar
• French SW. The Mallory body: structure, composition and pathogenesis. Hepatology 1981; 1: 76–83
   PubMedGoogle Scholar
• Barbatis C, Morton J, Woods JC, Burns J, Bradley J, McGee JOD. Disorganisation of intermediate filament structure in alcoholic and other liver diseases. Gut 1986; 27: 765–770
   PubMedGoogle Scholar
• Harinasuta U, Zimmerman HJ. Alcoholic steato-necrosis: relationship between severity of hepatic disease and presence of Mallory bodies in the liver. Gastroenterology 1967; 60: 1036–1045
   Google Scholar
• Baraona E, Leo M A, Borowsky S A, et al. Pathogenesis of alcohol-induced accumulation of protein in the liver. J Clin Invest 1977; 60: 546–554
   PubMed Web of Science ®Google Scholar
• Blendis L M, Orrego H, Crossley I R, et al. The role of hepatocyte enlargement in hepatic pressure in cirrhotic and noncirrhotic alcoholic liver disease. Hepatology 1982; 2: 539–546
   PubMedGoogle Scholar
• Tuma D J, Sorrell MF. Effects of ethanol on protein trafficking in the liver. Sem Liv Dis 1988; 8: 69–80
   PubMedGoogle Scholar
• Vidins E L, Britton R D, Medline A, Blendis L M, Israel Y, Orrego H. Sinusoidal caliber in alcoholic and nonalcoholic liver disease: diagnostic and pathogenic implications. Hepatology 1985; 5: 408–414
   PubMed Web of Science ®Google Scholar
• Krogsgaard K, Gluud C, Henriksen JH, Chris-Toffersen P. Correlation between liver morphology and portal pressure in alcoholic liver disease. Hepatology 1984; 4: 699–703
   PubMed Web of Science ®Google Scholar
• Krogsgaard K, Gluud C, Henriksen J H, Chris-Toffersen P. Correlation between liver morphology and haemodynamics in alcoholic liver disease. Liver 1985; 5: 173–177
   PubMedGoogle Scholar
• Orrego H, Medline A, Blendis L M, Rankin J G, Kreaden D A. Collagenisationof the Disse space in alcoholic liver disease. Gut 1979; 20: 673–679
   PubMed Web of Science ®Google Scholar
• Minato Y, Hasumura Y, Takeuchi J. The role of fat-storing cells in Disse space fibrogenesis in alcoholic liver disease. Hepatology 1983; 3: 559–566
   PubMedGoogle Scholar
• Mak K M, Leo M A, Lieber CS. Alcoholic liver injury in baboons. Transformation of lipocytes to transitional cells. Gastroenterollogy 1984; 87: 188–200
   PubMed Web of Science ®Google Scholar
• Horn T, Junge J, Christoffersen P. Early alcoholic liver injury. Activation of lipocytes in acinar zone 3 and correlation to degree of collagen formation in the Disse space. J Hepatol 1986; 3: 333–340
   PubMedGoogle Scholar
• Mak K M, Lieber CS. Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology 1988; 8: 1027–1033
   PubMed Web of Science ®Google Scholar
• Weiner F R, Giambrone M-A, Czaja M J, et al. Ito-cell gene expression and collagen regulation. Hepatology 1990; 11: 111–117
   PubMedGoogle Scholar
• Arenson D M, Friedman S L, Bissell DM. Formation of extracellular matrix in normal rat liver: lipocytes as a major source of proteoglycan. Gastroenterology 1988; 95: 441–447
   PubMedGoogle Scholar
• Van Waes L, Lieber CS. Early perivenular sclerosis in alcoholic fatty liver: an index of progressive liver injury. Gastroenterology 1977; 73: 646–650
   PubMedGoogle Scholar
• Worner T M, Lieber CS. Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 1985; 254: 627–630
   PubMedGoogle Scholar
• Nakano M, Worner T M, Lieber CS. Perivenular fibrosis in alcoholic liver injury: ultrastructure and histologic progression. Gastroenterology 1982; 83: 777–785
   PubMed Web of Science ®Google Scholar
• Mak K M, Lieber CS. Portal fibroblasts and myofibroblasts in baboon after long-term alcohol consumption. Arch Pathol Lab Med 1986; 110: 513–516
   PubMedGoogle Scholar
• Mak K M, Lieber CS. Alterations in endothelial fenestrations in liver sinusoids of baboons fed alcohol: a scanning electron microscopic study. Hepatology 1984; 4: 386–391
   PubMedGoogle Scholar
• Clark S A, Angus H B, Cook H BN, George P M, Oxner R B, Fraser R. Defenestration of hepatic sinusoids as a cause of hyperlipoproteinaemia in alcoholics. Lancet 1988; 2: 1225–1227
   PubMedGoogle Scholar
• Horn T, Christofferson P, Henriksen JH. Alcoholic liver injury: defenestration in noncirrhotic livers. A scanning electron microscopic study. Hepatology 1987; 7: 77–82
   PubMed Web of Science ®Google Scholar
• Naveau S, Poynard T, Abella A, et al. Prognostic value of serum fibronectin concentration in alcoholic cirrhotic patients. Hepatology 1985; 5: 819–823
   PubMedGoogle Scholar
• Junge J, Bentsen K D, Christoffersen P, Orholm M, Sorensen T IA, Horn T. Fibronectin as a predictor of cirrhosis in men who abuse alcohol. Br Med J 1988; 296: 1629–1630
   PubMedGoogle Scholar
• Junge J, Horn T, Christoffersen P. The occurrence and significance of fibronectin in livers from chronic alcoholics. APMIS 1988; 96: 56–61
   PubMedGoogle Scholar
• Nagore N, Scheuer PJ. Does a linear pattern of sinusoidal IgA deposition distinguish between alcoholic and diabetic liver disease?. Liver 1988; 8: 281–286
   PubMedGoogle Scholar
• Amano K, Tsukada K, Takeuchi Y, Fukuada Y, Nagura H. IgA deposition in alcoholic liver disease. An immunoelectron microscopic study. Am J Clin Pathol 1988; 89: 728–834
   PubMedGoogle Scholar
• Van de Wiel A, Van Hattum J, Schuuman H-J, Kater L. Immunoglobulin A in the diagnosis of alcoholic liver disease. Gastroenterology 1988; 94: 457–462
   PubMed Web of Science ®Google Scholar
• Horn T, Junge J, Christoffersen P. Early alcoholic liver injury: changes of the Disse space in acinar zone 3. Liver 1985; 5: 301–310
   PubMedGoogle Scholar
• Reynolds T B, Hidemura R, Michel H, Peters H, Peters R. Portal hypertension without cirrhosis in alcoholic liver disease. Ann Intern Med 1969; 70: 497–506
   PubMedGoogle Scholar
• French S W, Benson N C, Sun PS. Centrilobular liver necrosis induced by hypoxia in chronic ethanol-fed rats. Hepatology 1984; 4: 912–917
   PubMed Web of Science ®Google Scholar
• Maddrey WC. Propylthiouracil treatment of alcoholic hepatitis. Gastroenterology 1979; 76: 218–219
   PubMedGoogle Scholar
• Maddrey W C, Boitnott J K, Bedine M S, et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193–199
   PubMed Web of Science ®Google Scholar
• Carithers RL, Jr, Herlong H F, Diehl A M, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis: a randomized multi-center trial. Ann Intern Med 1989; 110: 685–690
   PubMed Web of Science ®Google Scholar
• Black M, Tavill AS. Corticosteroids in severe alcoholic hepatitis. Ann Intern Med 1989; 110: 677–680
   PubMed Web of Science ®Google Scholar
• Helman R A, Temko M H, Nye S W, Fallon HJ. Alcoholic hepatitis: natural history and evaluation of prednisolone therapy. Ann Intern Med 1971; 74: 311–321
   PubMed Web of Science ®Google Scholar
• Lesesne H R, Bozymski E M, Fallon HJ. Treatment of alcoholic hepatitis with encephalopathy: comparison of prednisolone with caloric supplements. Gastroenterology 1978; 74: 169–173
   PubMed Web of Science ®Google Scholar
• Porter H P, Simon F R, Pope CE, II, Volwiler W, Fenster F. Corticosteroid therapy in severe alcoholic hepatitis: a double-blind drug trial. N Engl J Med 1971; 284: 1350–1355
   PubMed Web of Science ®Google Scholar
• Campra JL, Hamlin EM, Kirshbaum RJ, Olivier M, Redeker AG, Reynolds TB. Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial. Ann Intern Med 1973; 79: 625–631
   PubMed Web of Science ®Google Scholar
• Schlichting P, Juhl E, Poulsen H, Winkel P. Alcoholic hepatitis superimposed on cirrhosis: clinical signifcance and effect of long-term prednisone treatment. Scand J Gastroenterol 1976; 11: 305–312
   PubMed Web of Science ®Google Scholar
• Blitzer B L, Mutchnick M G, Joshi P H, Phillips M M, Fessel J M, Conn HO. Adrenocorticosteroid therapy in alcoholic hepatitis: a prospective double-blind randomized study. Dig Dis 1977; 22: 477–484
   Google Scholar
• Schumacher J B, Resnick R H, Galambos J T, Makopour H, Iber FL. A controlled trial of 6-methylprednisone in acute alcoholic hepatitis. Am J Gastroenterol 1978; 69: 443–449
   PubMedGoogle Scholar
• Depew W, Boyer T, Omata M, Redeker A, Reynolds T. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology 1980; 78: 524–529
   PubMed Web of Science ®Google Scholar
• Theodossi A, Eddleston A LWF, Williams R. Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. Gut 1982; 23: 75–79
   PubMed Web of Science ®Google Scholar
• Orrego H, Kalant H, Israel Y, et al. Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease. Gastroenterology 1979; 76: 105–115
   PubMed Web of Science ®Google Scholar
• Weiner F R, Czaja M J, Giambrone M-A, Tak-Ahashi S, Biempica L, Zern MA. Transcriptional and posttranscriptional effects of dexamethasone on albumin and procollagen messenger RNAs in murine schistosomiasis. Biochemistry 1987; 26: 1557–1562
   PubMedGoogle Scholar
• Weiner F R, Czaja M J, Jefferson D M, et al. The effects of dexamethasone on in vitro collagen gene expression. J Biol Chem 1987; 262: 6955–6958
   PubMed Web of Science ®Google Scholar
• Jefferson D M, Reid LM, Giambrone M-A, Shaf-Ritz DA, Zern MA. Effects of dexamethasone on albumin and collagen gene expression in primary cultures of adult rat hepatocytes. Hepatology 1985; 5: 14–20
   PubMed Web of Science ®Google Scholar
• Orrego H, Blake J E, Blendis L M, et al. Longterm treatment of alcoholic liver disease with propylthiouracil. N Engl J Med 1987; 317: 1421–1427
   PubMed Web of Science ®Google Scholar
• Halle P, Pare P, Kaptein E, Kanel G, Redeker A G, Reynolds TB. Double-blind, controlled trial of propylthiouracil in severe acute alcoholic hepatitis. Gastroenterology 1982; 82: 925–931
   PubMed Web of Science ®Google Scholar
• Kaplowitz N. Propylthiouracil treatment for alcoholic hepatitis: should it and does it work?. Gastroenterology 1982; 82: 1468–1471
   PubMedGoogle Scholar
• Mendenhall C L, Anderson S, Garci-Pont P, et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 1984; 311: 1464–1479
   PubMed Web of Science ®Google Scholar
• Leevy CM. Fatty liver: a study of 270 patients with biopsy proven fatty liver and a review of the literature. Medicine 1962; 41: 249–278
   PubMed Web of Science ®Google Scholar
• Fenster LF. The nonefficacy of short-term anabolic steroid therapy in alcoholic liver disease. Ann Intern Med 1966; 65: 738–744
   Web of Science ®Google Scholar
• Baker A L, Jaspan J B, Haines N W, et al. A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients. Gastroenterology 1981; 80: 1410–1414
   PubMed Web of Science ®Google Scholar
• Feher J, Cornides A, Romany A, et al. A prospective multicenter study of insulin and glucagon infusion therapy in acute alcoholic hepatitis. J Hepatol 1987; 5: 224–231
   PubMed Web of Science ®Google Scholar
• Leffert HL, Koch KS, Moran T, Rubalcava B. Hormonal control of rat liver regeneration. Gastroenterology 1979; 76: 1470–1482
   PubMed Web of Science ®Google Scholar
• Maddrey WC. Insulin and glucagon therapy for alcoholic hepatitis. Gastroenterology 1981; 80: 1596–1598
   PubMedGoogle Scholar
• Galambos J T, Hersh T, Gulenwider J T, et al. Hyperalimentation in alcoholic hepatitis. Am J Gastroenterol 1979; 72: 535–541
   PubMed Web of Science ®Google Scholar
• Nasrallah S M, Galambos JT. Amino acid therapy of alcoholic hepatitis. Lancet 1980; 2: 1276–1277
   PubMed Web of Science ®Google Scholar
• Naveau S, Pelletier G, Poynard T, et al. A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patients. Hepatology 1986; 6: 270–274
   PubMedGoogle Scholar
• Calvey H, Davis M, Williams R. Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis. J Hepatol 1985; 1: 141–151
   PubMedGoogle Scholar
• Simon D, Galambos J T. A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis. J Hepatol 1988; 7: 200–207
   PubMed Web of Science ®Google Scholar
• Diehl A M, Boitnott J K, Herlong H F, et al. Effect of parenteral amino acid supplementation in alcoholic hepatitis. Hepatology 1985; 5: 57–63
   PubMedGoogle Scholar
• Kershenobich D, Vargas F, Garcia-Tsao G, et al. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med, 318: 1709–1713
   PubMedGoogle Scholar
• Trinchet J-C, Beaugrand M, Callard P, et al. Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial. Gastroenterol Clin Biol 1989; 13: 551–555
   PubMedGoogle Scholar